Autoimmunity

Response to ‘Antinuclear antibodies by indirect immunofluorescence and solid phase assays’ by Bossuyt et al
David S Pisetsky, Diane M Spencer, Peter E Lipsky, Brad H Rovin

Annals of the Rheumatic Diseases Jun 2020, 79 (6) e66; DOI: 10.1136/annrheumdis-2019-215479
Utility of the HEp-2000 antinuclear antibody substrate
Adrian Y S Lee, Dimitra Beroukas, Peter J Roberts-Thomson

Annals of the Rheumatic Diseases Jun 2020, 79 (6) e67; DOI: 10.1136/annrheumdis-2019-215519
Response to: ‘Could autologous adipose-derived stromal vascular fraction turn out an unwanted source of profibrotic myofibroblasts in systemic sclerosis?’ by Manetti
Melanie Velier, Jeremy Magalon, Stephanie Simoncini, Françoise Dignat-George, Brigitte Granel, Pascale Paul, Florence Sabatier

Annals of the Rheumatic Diseases May 2020, 79 (5) e56; DOI: 10.1136/annrheumdis-2019-215327
Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress
Tom WJ Huizinga, V Michael Holers, Jennifer Anolik, Michael B Brenner, Christopher Dominic Buckley, Vivian Bykerk, Sean E Connolly, Kevin D Deane, Jianping Guo, Martin Hodge, Steve Hoffmann, Frank Nestle, Costantino Pitzalis, Soumya Raychaudhuri, Kazuhiko Yamamoto, Zhanguo Li, Lars Klareskog

Annals of the Rheumatic Diseases May 2020, 79 (5) 553-555; DOI: 10.1136/annrheumdis-2019-216846
2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et al
Byung-Woo Yoo, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee

Annals of the Rheumatic Diseases Feb 2020, annrheumdis-2020-217086; DOI: 10.1136/annrheumdis-2020-217086
Chronic inflammatory arthritis following checkpoint inhibitor therapy for cancer: game changing implications
Leonard Calabrese, Xavier Mariette

Annals of the Rheumatic Diseases Mar 2020, 79 (3) 309-311; DOI: 10.1136/annrheumdis-2019-216510
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
Brian Skaug, Dinesh Khanna, William R Swindell, Monique E Hinchcliff, Tracy M Frech, Virginia D Steen, Faye N Hant, Jessica K Gordon, Ami A Shah, Lisha Zhu, W Jim Zheng, Jeffrey L Browning, Alexander M S Barron, Minghua Wu, Sudha Visvanathan, Patrick Baum, Jennifer M Franks, Michael L Whitfield, Victoria K Shanmugam, Robyn T Domsic, Flavia V Castelino, Elana J Bernstein, Nancy Wareing, Marka A Lyons, Jun Ying, Julio Charles, Maureen D Mayes, Shervin Assassi

Annals of the Rheumatic Diseases Mar 2020, 79 (3) 379-386; DOI: 10.1136/annrheumdis-2019-215894
Response to: ‘Role of linoleic acid in autoimmune disorders: aMendelian randomisation study’ by Lee et al
Jie V Zhao, C Mary Schooling

Annals of the Rheumatic Diseases Mar 2020, 79 (3) e29; DOI: 10.1136/annrheumdis-2018-214830
Can solid-phase assays replace immunofluorescence for ANA screening?
Nicola Bizzaro

Annals of the Rheumatic Diseases Mar 2020, 79 (3) e32; DOI: 10.1136/annrheumdis-2018-214805
Response to: ‘Dupilumab as a potential steroid-sparing treatment for IgG4-related disease’ by Della-Torre et al
Rachel S Simpson, Jason K Lee

Annals of the Rheumatic Diseases Feb 2020, annrheumdis-2020-216955; DOI: 10.1136/annrheumdis-2020-216955

Main menu

Autoimmunity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Autoimmunity

Pages